LPCAT2 and colorectal cancer: Abnormal biosynthesis of phosphatidylcholine, facilitated by the lipid droplet-bound enzyme lysoRS acyltransferase 2 (LPCAT2) has been found to contribute to resistance to oxaliplatin in colorectal cancer [24].